−0.33 EUR
−14.26 M EUR
102.31 M EUR
3.84 M
About MATERNUS KLINIKEN
Sector
Industry
CEO
Mario Augusto Ruano-Wohlers
Website
Headquarters
Berlin
Founded
2008
ISIN
DE0006044001
FIGI
BBG000BM1HT8
Maternus-Kliniken AG engages in the operation of senior housing facilities, nursing homes, and rehabilitation centers. It operates through the Nursing Care and Rehabilitation segments. The Nursing Care segment specializes in full-station services care, short-term care, and assisted living. The Rehabilitation segment comprises follow-up treatment and rehabilitation measures in the areas orthopedics, behavioral orthopedics, cardiology, internal medicine, metabolic disorders, as well as neurology. The company was founded in 1877 and is headquartered in Berlin, Germany.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MAK is 1.39 EUR — it has decreased by −5.44% in the past 24 hours. Watch MATERNUS KLINIKEN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange MATERNUS KLINIKEN stocks are traded under the ticker MAK.
MAK stock has fallen by −9.15% compared to the previous week, the month change is a −12.58% fall, over the last year MATERNUS KLINIKEN has showed a −51.40% decrease.
MAK stock is 5.76% volatile and has beta coefficient of 0.87. Track MATERNUS KLINIKEN stock price on the chart and check out the list of the most volatile stocks — is MATERNUS KLINIKEN there?
Yes, you can track MATERNUS KLINIKEN financials in yearly and quarterly reports right on TradingView.
MAK net income for the last half-year is −1.84 M EUR, while the previous report showed −5.04 M EUR of net income which accounts for 63.39% change. Track more MATERNUS KLINIKEN financial stats to get the full picture.
No, MAK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 1.99 K employees. See our rating of the largest employees — is MATERNUS KLINIKEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MATERNUS KLINIKEN EBITDA is 12.42 M EUR, and current EBITDA margin is −5.45%. See more stats in MATERNUS KLINIKEN financial statements.
Like other stocks, MAK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MATERNUS KLINIKEN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MATERNUS KLINIKEN technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MATERNUS KLINIKEN stock shows the strong sell signal. See more of MATERNUS KLINIKEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.